<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01983345</url>
  </required_header>
  <id_info>
    <org_study_id>P121103</org_study_id>
    <secondary_id>2013-A00385-40</secondary_id>
    <nct_id>NCT01983345</nct_id>
  </id_info>
  <brief_title>Prenatal Surgical Repair of Fetal Myelomeningocele</brief_title>
  <acronym>PRIUM</acronym>
  <official_title>Prenatal Surgical Repair of Fetal Myelomeningocele</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The open surgical repair of myelomeningoceles before 26 weeks gestational age provides a&#xD;
      correction of the anomaly of Chiarri, reduces the incidence of ventriculomegaly (defined as a&#xD;
      measure of the ventricles at the crossroads ≥ 10 mm), and get a lower of injury than one&#xD;
      corresponding to the anatomical defect (as defined by the last upper normal vertebra before&#xD;
      the defect).&#xD;
&#xD;
      The purpose of this study is to introduce in France an innovative technique for prenatal&#xD;
      repair of myelomeningocele until now developed only on the American continent.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spina bifida (SB) represents one of the most severe congenital malformation of the central&#xD;
      nervous system and amenable to prenatal diagnosis. In the past 20 years, prenatal repair of&#xD;
      SB has become an established technique.&#xD;
&#xD;
      The PRIUM study will include 10 cases of fetuses with prenatal diagnosis of SB and for whom&#xD;
      the maternal willing will be to continue the pregnancy. A surgical prenatal repair of the&#xD;
      defect will be planed at 19-25+6 weeks gestation following maternal laparotomy and&#xD;
      hysterotomy under maternal general anesthesia. The delivery will be planed at 36 weeks'.&#xD;
      Postnatal evaluation of the neonates will be scheduled at birth, 1 month, 12 months and 36&#xD;
      months of age. Those data will be matched to controls who have underwent a conventional&#xD;
      postnatal repair of the SB&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 10, 2014</start_date>
  <completion_date type="Actual">July 28, 2021</completion_date>
  <primary_completion_date type="Actual">July 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arnold Chiari anomaly at birth</measure>
    <time_frame>Day 0</time_frame>
    <description>the existence of an Arnold Chiari anomaly at birth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defect</measure>
    <time_frame>3 years</time_frame>
    <description>the level difference between the observed level of injury and the anatomical level of the defect (as defined by the last normal upper vertebra before the defect)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Foetus With Myelomeningocele</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No prenatal surgical repair of myelomeningocele</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Case - open surgical repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prenatal surgical repair of fetal myelomeningocele</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>prenatal surgical repair of fetal myelomeningocele</intervention_name>
    <description>open surgical repair of myelomeningocele before 26 weeks gestational age</description>
    <arm_group_label>Case - open surgical repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient of majority age, with an assumption by health insurance, understanding and&#xD;
             speaking French&#xD;
&#xD;
          -  A term between 19 and 25 +6 weeks gestational age (not for control)&#xD;
&#xD;
          -  Single-Pregnancy&#xD;
&#xD;
          -  Normal fetal karyotype&#xD;
&#xD;
          -  Myelomeningocele with higher-level defect between S1 and T1&#xD;
&#xD;
          -  Placenta not low-inserted or not covering&#xD;
&#xD;
          -  Fault-isolated ultrasound reference&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18 years&#xD;
&#xD;
          -  Patient foreigner who understands not French&#xD;
&#xD;
          -  Multiple Pregnancy&#xD;
&#xD;
          -  Low Placenta inserted or covering&#xD;
&#xD;
          -  Severe kyphosis&#xD;
&#xD;
          -  Placental abruption&#xD;
&#xD;
          -  Fetal malformation unrelated to the existence of myelomeningocele (the existence of a&#xD;
             malposition of one or both feet do not represent an exclusion criterion)&#xD;
&#xD;
          -  Increased risk of preterm birth: a history of preterm delivery before 37 weeks&#xD;
             gestational age, cervical length &lt;26 mm before 26 weeks gestational age (not for&#xD;
             control)&#xD;
&#xD;
          -  Bleeding active between 20 and 26 weeks gestational age (not for control)&#xD;
&#xD;
          -  Maternal obesity with BMI&gt; 35 (not for control)&#xD;
&#xD;
          -  History of uterine surgery involving the anterior surface of the uterus (not for&#xD;
             control)&#xD;
&#xD;
          -  Maternal contradiction in surgery or general anesthesia (not for control)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Zerah, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Marie Jouannic, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Armand Trousseau, APHP</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 7, 2013</study_first_submitted>
  <study_first_submitted_qc>November 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2013</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myelomeningocele</keyword>
  <keyword>Arnold Chiari malformation</keyword>
  <keyword>Spina bifida</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningomyelocele</mesh_term>
    <mesh_term>Spina Bifida Cystica</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

